Hostname: page-component-54dcc4c588-wlffp Total loading time: 0 Render date: 2025-10-05T11:37:27.346Z Has data issue: false hasContentIssue false

Associations between psychotic experience dimensions and polygenic liability to schizophrenia in a longitudinal birth cohort

Published online by Cambridge University Press:  08 September 2025

Alastair G. Cardno*
Affiliation:
Division of Psychological and Social Medicine, University of Leeds, UK
Hein Heuvelman
Affiliation:
Division of Psychological and Social Medicine, University of Leeds, UK Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, UK
Sophie E. Legge
Affiliation:
Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
James T. R. Walters
Affiliation:
Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK
Stanley Zammit
Affiliation:
Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Population Health Sciences, Bristol Medical School, Bristol, UK NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, UK
Hannah J. Jones
Affiliation:
Medical Research Council Integrative Epidemiology Unit at the University of Bristol, Population Health Sciences, Bristol Medical School, Bristol, UK NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, UK
*
Correspondence: Alastair G. Cardno. Email: a.g.cardno@leeds.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

Some psychotic experiences in the general population show associations with higher schizophrenia and other mental health-related polygenic risk scores (PRSs), but studies have not usually included interviewer-rated positive, negative and disorganised dimensions, which show distinct associations in clinical samples.

Aims

To investigate associations of these psychotic experience dimensions primarily with schizophrenia PRS and, secondarily, with other relevant PRSs.

Method

Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort participants were assessed for positive, negative and disorganised psychotic experience dimensions from interviews, and for self-rated negative symptoms, at 24 years of age. Regression models were used to investigate associations between psychotic experience dimensions and schizophrenia and other PRSs (2500+ participants for each analysis).

Results

Against expectation, none of the positive, negative or disorganised dimensions was associated with schizophrenia PRS. In secondary analysis, self-rated negative symptoms were associated with higher depression (β = 0.10 [95% CI 0.06–0.15]), anxiety (β = 0.09 [95% CI 0.04–0.13]), neuroticism (β = 0.11 [95% CI 0.06–0.15]) and autism (β = 0.09 [95% CI 0.05–0.13]) PRSs (all P < 0.001); and first-rank delusions were nominally associated with higher schizophrenia PRS (odds ratio 7.35 [95% CI 2.10–25.77], P = 0.002), although these experiences/symptoms were rare.

Conclusions

Positive, negative and disorganised psychotic experiences are probably not strongly associated with polygenic liability to schizophrenia in this general population cohort of young adults. Self-rated negative symptoms may indicate social withdrawal/low motivation due to higher polygenic liability to affective disorders or autism, and first-rank delusions may indicate higher polygenic liability to schizophrenia, but these findings require independent confirmation.

Information

Type
Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Schizophrenia and related psychoses show considerable symptom variation, whose pattern of co-occurrence can be summarised by factor analysis into three main dimensions of broadly defined psychotic symptoms: positive (delusions and hallucinations), negative (restricted speech and affect, reduced motivation and socialisation) and disorganised (formal thought disorder, incongruous/inappropriate affect and bizarre behaviour).Reference Dazzi and Shafer1 Subdivisions or merging of dimensions can also occur, depending on which symptoms are included,Reference Cardno, Jones, Murphy, Sanders, Asherson and Owen2Reference Fanous, Zhou, Aggen, Bergen, Amdur and Duan4 e.g. first-rank symptoms as a subdivision of the positive dimension, or a combined negative/disorganised dimension. Affective symptomsReference Quattrone, Reininghaus, Richards, Tripoli, Ferraro and Quattrone5 and cognitive abilitiesReference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6 are also sometimes included in analyses.

There are notable differences in symptom dimension associations, which may reflect some aetiological differences. For example, positive symptoms are most responsive to antipsychotic medication,Reference Tandon, Nasrallah, Akbarian, Carpenter, DeLisi and Gaebel7 negative symptoms are most strongly associated with chronic illness courseReference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 and disorganised symptoms show the most consistent evidence for substantial heritability.Reference Rietkerk, Boks, Sommer, Liddle, Ophoff and Kahn9,Reference Rijsdijk, Gottesman and Cardno10 This highlights the value of investigating positive, negative and disorganised dimensions as separate, although related, phenotypes.

In addition to clinical symptoms, a range of milder psychotic experiences occur. In view of this, research based on clinical samples can be complemented by investigations of longitudinal birth cohorts,Reference Ronald, Sieradzka, Cardno, Haworth, McGuire and Freeman11,Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12 which include (a) a relatively well-defined population; (b) prospective assessments of risk factors and a broad range of relevant phenotypes from subclinical psychotic experiences to symptoms; and (c) the opportunity to observe how associations develop with age and less influence from factors such as medication effects, that can occur in clinical samples.

Longitudinal population-based research is being conducted, but often with questionnaire measures of experiences/symptoms or in relatively small samples, whereas assessments in clinical samples are normally based on responses to structured or semi-structured interview questions, interviewers’ observations and review of clinicians’ observations in case records.

The Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohortReference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 (http://www.bristol.ac.uk/alspac) is distinctive, in that it includes large-scale data on psychotic experiences/symptoms from both semi-structured interview questions and interviewers’ observations up to age 24 years, around the peak age at onset of schizophrenia.Reference Tandon, Nasrallah, Akbarian, Carpenter, DeLisi and Gaebel7 The data including interviewers’ observations have not been previously studied, and are valuable for assessing negative and disorganised symptoms. This makes ALSPAC well suited for investigation of psychotic experience/symptom dimensions and their associations with schizophrenia risk factors, the main focus being on genetic risk factors in the current study.

Genetic risk factors

Schizophrenia has a high heritability, of 60–80%.Reference Tandon, Nasrallah, Akbarian, Carpenter, DeLisi and Gaebel7,Reference Owen, Legge, Rees, Walters and O’Donovan15 Among psychotic symptom dimensions, the disorganised dimension shows most consistent evidence of significant familial aggregationReference Cardno, Jones, Murphy, Sanders, Asherson and Owen2,Reference Rietkerk, Boks, Sommer, Liddle, Ophoff and Kahn9 and has substantial twin heritability (∼80%),Reference Rijsdijk, Gottesman and Cardno10 while the positive and negative dimensions show less consistent familial aggregation.Reference Rietkerk, Boks, Sommer, Liddle, Ophoff and Kahn9

In molecular genetic studies, higher scores on disorganised, negative/disorganised and sometimes negative dimensions are associated with a higher schizophrenia polygenic risk score (PRS),Reference Fanous, Zhou, Aggen, Bergen, Amdur and Duan4,Reference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6,Reference Taylor, de Vries, van Loo and Kendler16,Reference Ahangari, Bustamante, Kirkpatrick, Nguyen, Verrelli and Fanous17 a measure of genetic loading for schizophrenia due to common genetic variants.

Additionally, the positive dimension is associated with schizophrenia PRS in some,Reference Quattrone, Reininghaus, Richards, Tripoli, Ferraro and Quattrone5,Reference Smigielski, Papiol, Theodoridou, Heekeren, Gerstenberg and Wotruba18Reference Allardyce, Cardno, Gordon-Smith, Jones, Di Florio and Walters20 but not all,Reference Jonas, Lencz, Li, Malhotra, Perlman and Fochtmann21,Reference Sengupta, MacDonald, Fathalli, Yim, Lepage and Iyer22 studies that include other psychotic or bipolar disorders.

Psychotic experiences/symptoms in the general population show factor-derived dimensions similar to clinical samples,Reference Ronald, Sieradzka, Cardno, Haworth, McGuire and Freeman11,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 (although observer-rated disorganised symptoms have usually not been included) and are associated with family history of psychosis.Reference Ronald, Sieradzka, Cardno, Haworth, McGuire and Freeman11 Schizophrenia PRS has been associated with the positive and negative dimensionsReference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14,Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23Reference Docherty, Shabalin, Adkins, Mann, Krueger and Bacanu25 and self-rated cognitive disorganisation.Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23 Most studies have been based on self- or parent-rated questionnaires. One study based on a schizotypy interview found associations with positive and negative/disorganised dimensions.Reference Van Os, Van der Steen, Islam, Gülöksüz, Rutten and Simons26 A further study investigated positive, negative and disorganised dimensions using a clinical research interview but found no significant associations, possibly because of the small sample size (n = 148).Reference Derks, Vorstman, Ripke and Kahn27

Previous investigations in ALSPAC have shown an association between schizophrenia PRS and the negative dimension at age 16 years, as assessed by the self-rated Community Assessment of Psychic Experiences (CAPE) questionnaireReference Konings, Bak, Hanssen, van Os and Krabbendam28 and defined as a categorical cut-off score,Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13 and by quantitative factor scores from correlated factors and bifactor models.Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14

Schizophrenia PRS was also associated with the positive dimension in the correlated factors model,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 based on self-report at 16 years.

Additionally, in a study that combined ALSPAC and other samples, schizophrenia PRS was associated with a parent-rated negative dimension at 16 years.Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23

In summary, in schizophrenia samples polygenic loading for schizophrenia is most associated with the disorganised or negative/disorganised dimensions. In samples including other psychoses and population-based samples there is sometimes an additional association with the positive dimension, possibly because these samples include a broader range of positive experience/symptom severity.

However, associations between psychotic experience dimensions and schizophrenia PRS may not be specific, because they have also been found with other PRSs, including those for depression, neuroticism and autism.Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14,Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23Reference Docherty, Shabalin, Adkins, Mann, Krueger and Bacanu25

In the current study, we extended the ALSPAC investigations to include four primary dimensions derived from (a) interview-based positive psychotic experiences (defined broadly from mild experiences to symptoms), (b) interviewer-observed negative symptoms, (c) interviewer-observed disorganised symptoms and (d) self-rated negative symptoms; to assessments up to 24 years; and to a newer, more powerful, schizophrenia PRS.Reference Trubetskoy, Pardiñas, Qi, Panagiotaropoulou, Awasthi and Bigdeli29

Study aims

The primary aim of this study was to investigate associations between psychotic experience dimensions assessed at 24 years and schizophrenia PRS. We hypothesised that all three dimensions based on interview would be associated with schizophrenia PRS, with effect sizes disorganised > negative > positive. We additionally hypothesised that the self-rated negative dimension, based on the CAPE questionnaire, would be associated with schizophrenia PRS at 24 years, as previously found in ALSPAC at 16 years.Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14

Secondary aims were to: (a) investigate associations of individual psychotic experiences with schizophrenia PRS, in case any were hidden by being combined in broader experience dimensions; (b) investigate associations of psychotic experience dimensions with other relevant PRSs, to assess how specific any associations with schizophrenia PRS were; (c) investigate the broader profile of associations of psychotic experience dimensions with demographic variables, developmental risk factors and affective disorders, in order to further contextualise the dimensions and their PRS associations; and (d) investigate the profile of these associations with psychotic disorder, in order to highlight any notable differences between psychotic experiences and symptoms.

Method

Study sample

Pregnant women residing in Avon, UK, with expected dates of delivery between 1 April 1991 and 31 December 1992 (enrolled, n = 14 541; live births alive at 1 year, n = 13 988), were invited to take part in ALSPAC.Reference Boyd, Golding, Macleod, Lawlor, Fraser and Henderson30Reference Northstone, Lewcock, Groom, Boyd, Macleod and Timpson32 An additional 913 children who would have been eligible but whose mothers did not enrol during pregnancy were enrolled after age 7 years, resulting in a total sample of 14 901 children alive at age 1 year. There were 3866 participants at 24 years (56% female, 97% of White ethnicity).Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12 Between age 12 and 24 years, 313 (8.1%) had had a definite positive psychotic experience and 109 (2.8%) had a psychotic disorder.Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12

Study data were collected and managed using Research Electronic Data Capture (REDCap) electronic data capture tools hosted at the University of Bristol.Reference Harris, Taylor, Thielke, Payne, Gonzalez and Conde33 REDCap is a secure, web-based software platform designed to support data capture for research studies.

The study website contains details of all the available data through a fully searchable data dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/).

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation, and with the Helsinki Declaration of 1975 as revised in 2013. All procedures involving human subjects/patients had ethical approval from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (details at http://www.bristol.ac.uk/alspac/researchers/research-ethics/; approval for 24-year assessments: National Research Ethics Service Committee South West – Frenchay: no. 14/SW/1173). All participants gave written informed consent.

Assessment of psychotic experience/symptom dimensions

Three psychotic experience/symptom dimensions were derived from interview and one from questionnaire.

Interview-based psychotic experience/symptom dimensions were defined in terms of the semi-structured Psychosis-Like Symptom Interview (PLIKS)Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12 questions and interviewer observations at 24 years. Interview questions asked about experiences and symptoms occurring between 12 and 24 years (see Supplementary Method available at https://doi.org/10.1192/bjo.2025.10825 for further details regarding PLIKS).

We defined psychotic experience dimensions based on the most consistent core psychotic symptoms in dimensions derived from factor analysis of clinical samplesReference Dazzi and Shafer1,Reference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6 and psychotic experiences in population samples.Reference Ronald, Sieradzka, Cardno, Haworth, McGuire and Freeman11,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 Psychotic experiences were defined to match as closely as possible core symptoms from our studies of clinical psychotic symptom dimensions,Reference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 in order to facilitate comparison between the current population-based study and studies of clinical samples. In these studies, each dimension comprised two core symptoms (e.g. hallucinations and delusions for the positive dimension) and was scored from 0 to 2 according to how many of the core symptoms were present.

The overarching term psychotic experiences was used broadly in this study, to include both milder subclinical experiences and also symptoms (where there was significant distress or impairment), both subjective experiences described at interview, or in a questionnaire, and behaviour observed by interviewers. Within this, we referred to positive psychotic experiences, negative symptoms and disorganised symptoms, to follow common usage.Reference Ronald, Sieradzka, Cardno, Haworth, McGuire and Freeman11,Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14

Definitions of psychotic experience dimensions were as follows:

  1. (a) positive dimension (Pos, scored 0–2): comprising any auditory or visual hallucination experience (score 1) and any delusion experience, including thought insertion/withdrawal/broadcast (score 1), rated at interview as definitely present and occurring between 12 and 24 years. Experiences that occurred only when waking up/falling asleep, with fever or under the influence of alcohol/drugs were not included;

  2. (b) negative dimension (Neg, scored 0–2): comprising reduced interaction/speech (score 1) and restricted affect (score 1), rated as clearly present at interview;

  3. (c) disorganised dimension (Dis, scored 0–2): comprising incoherent speech (score 1) and odd/inappropriate behaviour (score 1), rated as clearly present at interview;

See Supplementary file ‘Observed ratings from interview’ for the Neg and Dis symptom rating guide.

Neg and Dis symptoms were more likely to be observed if they were frequently occurring or easily evoked by the effort of being interviewed than if they were occasional and transient.

The distributions of dimension scores are shown in Table 1. Because the number of participants with scores of 2 was low, we dichotomised scores into a broad definition (regarded as present if either of the core experiences was present: score 0 versus 1–2). This was the primary definition for analysis.

Table 1 Distribution of psychotic experience dimension scores from interview assessments

a. Psychotic experience dimension score based on the number of experiences/symptoms assessed as being present.

b. Positive dimension comprised hallucination and delusion experiences assessed by interviewer as being present at 12–24 years.

c. Negative dimension comprised reduced interaction/speech and restricted affect observed at interview at 24 years.

d. Disorganised dimension comprised incoherent speech and odd/inappropriate behaviour observed at interview at 24 years.

We also employed a narrow definition (regarded as present if both core experiences were present: score 0–1 versus 2). If there were substantial numbers of participants scoring 1 and 2, we would expect variables associated with a dimension to show an association with the broad definition and an association of a similar or greater effect size with the narrow definition, as seen in clinical samples.Reference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 However, in the current study we confined investigation of the narrow definition to secondary analysis due to the low number of participants scoring 2 for dimensions, and in case the results could be combined with those from other samples in future meta-analyses.

We have dichotomised in a similar way to this in previous research on clinical samples where symptom dimension scores of 2 were uncommon.Reference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8

Additionally, broad Pos is similar to the presence/absence of any psychotic experience as used in other ALSPAC investigations,Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13,Reference Siebald, Khandaker, Zammit, Lewis and Jones34 allowing contextualisation and comparison with results of these studies.

  1. (d) Self-rated negative dimension (self-rated Neg, scored 0–30): comprising the sum score of the 10 items relating to low emotional expression, motivation and socialisation in the CAPE questionnaireReference Konings, Bak, Hanssen, van Os and Krabbendam28 (each scored 0–3: never, sometimes, often, nearly always, respectively), completed at 24 years, regarding symptoms in the past month.

See Supplementary Method for further details about the CAPE questionnaire and Supplementary file ‘CAPE questions’ for the questions used.

We defined dimensions as simple sum scores, rather than conduct a factor analysis and derive factor scores, because of the different time frames and modes of assessment for the various experiences. Also, compared with factor scores, sum scores were easier to interpret and compare with the results of studies in clinical samples where corresponding symptom definitions were used.

Spearman correlations between dimensions ranged from 0.02 (Neg and self-rated Neg) to 0.36 (Neg and Dis; Supplementary Table 1).

Polygenic risk score (PRS) analysis

The primary analysis was of schizophrenia PRS, derived from the White European ancestry sample of the PGC3 schizophrenia Genome-Wide Association Study (GWAS).Reference Trubetskoy, Pardiñas, Qi, Panagiotaropoulou, Awasthi and Bigdeli29

PRSs were calculated for each ALSPAC individual using PLINK version 1.07 (https://zzz.bwh.harvard.edu/plink)Reference Purcell, Neale, Todd-Brown, Thomas, Ferreira and Bender35 by summing the number of risk alleles for each single nucleotide polymorphism (SNP) weighted by GWAS discovery sample effect size.

See Supplementary Method for further details on the genetic data and PRS calculation.

We used standardised scores generated from a list of SNPs, with a GWAS discovery sample P-value threshold (P T) ≤ 0.05 in regression models, to evaluate associations between PRS and psychotic experience dimensions: logistic regression for the interview-based dimensions, and linear regression for self-rated Neg, with CAPE scores square-root transformed due to the positive skew of data distribution. The transformation optimised the phenotype for linear regression analysis, but with the trade-off of reducing variability, especially of higher scores, and making real-world interpretation of the results less straightforward.

We restricted the PRS analysis to participants of White European ancestry (97% of the sample) and adjusted for gender and the first 10 population genetic ancestry principal components.

We treated primary analysis associations as statistically significant at P < 0.05, two-tailed, following adjustment for a Benjamini–Hochberg false discovery rate (FDR; 0.05) based on analyses of the four primary psychotic experience dimension phenotypes, in SPSS version 29 for Mac (IBM, Armonk, NY, USA; https://www.ibm.com/spss).

Secondary analysis

In case any associations with individual psychotic experiences were hidden within the dimension results, we conducted associations between schizophrenia PRS and the presence/absence of the six individual psychotic experiences from the PLIKS interview that contributed to the dimensions, using logistic regression as in the primary analysis.

In order to assess how specific the schizophrenia PRS associations were, we conducted secondary analysis of associations between psychotic experience dimensions and other potentially relevant PRSs available in ALSPAC at the time of analysis: psychotic experiences in middle-aged/older adults, depression, anxiety, neuroticism and autism. We used the same methods as for the schizophrenia PRS analysis.

To give context and possible insights into the primary results, we also investigated associations of the psychotic experience dimensions with demographics, developmental risk factors, affective disorders, quality of life and social rapport variables. Finally, we conducted the primary and secondary analyses using psychotic disorder as the phenotype to gain insights into similarities and differences compared with broader positive psychotic experiences. See Supplementary Method for further details.

Analyses were conducted using logistic or linear regression models, with the psychotic experience dimension or psychotic disorder as the dependent variable and the demographic/risk factor as the independent variable, adjusted for gender (except the analysis of gender), in SPSS version 29 for Mac.

For all secondary analyses, in the results tables we indicate those results that are statistically significant at P < 0.05, P < 0.01 and P < 0.001, two-tailed and, in the text description and discussion of these results, focused on those with P < 0.001, describing these as associated while describing results at P < 0.01 as nominally associated.

Results

Associations between psychotic experience dimensions and schizophrenia PRS

The results of the primary analysis of associations between the four psychotic experience dimensions and schizophrenia PRS are shown in Table 2, with further details and descriptive statistics in Supplementary Tables 26 and Supplementary Figs 1 and 2. None of the associations was statistically significant.

Table 2 Regression analysis of psychotic experience dimensions on polygenic risk scoresa

OR, odds ratio (1.00 = no effect); β, beta-coefficient (0 = no effect).

a. Logistic regression for interviewer-rated experiences/symptoms and linear regression for self-rated negative symptoms, using PRS standardised scores based on a Genome-Wide Association Study discovery sample threshold of P = 0.05, restricted to White ethnicity, adjusted for gender and 10 population genetic ancestry principal components.

b. Present if hallucination or delusion experience assessed by interviewer as being present at 12–24 years.

c. Present if reduced interaction/speech or restricted affect observed at interview at 24 years.

d. Present if incoherent speech or odd/inappropriate behaviour observed at interview at 24 years.

e. Sum score (0–30) of self-rated negative symptom questions from Community Assessment of Psychic Experiences (CAPE) questionnaire at 24 years (scores square-root transformed because of positive skew).

f. Psychotic experiences in middle-aged/older adults.

***P < 0.001, two-tailed.

The results of secondary analysis of the narrow Pos, Neg and Dis dimensions are shown in Supplementary Tables 25, and associations were also non-significant.

Associations between individual psychotic experiences and schizophrenia PRS

The results of this secondary analysis are shown in Supplementary Table 7; again these were non-significant.

Associations between psychotic experience dimensions and other PRSs

The results of this secondary analysis are shown in Table 2, with further details in Supplementary Tables 25 and Supplementary Figs 1 and 2.

None of the broad or narrow Pos, Neg or Dis dimensions showed associations at P < 0.001.

Higher self-rated Neg scores were associated (P < 0.001) with higher depression, anxiety, neuroticism and autism PRSs. However, effect sizes were too small (β = 0.09–0.11) to be clinically actionable at present.

Associations between psychotic experience dimensions and other variables

The results of this secondary analysis are shown in Supplementary Tables 25.

Broad Pos was associated (P < 0.001) with lower IQ at 8 years, lower mental well-being at 23 years, depressive and generalised anxiety disorders at 24 years and lower social rapport at 24 years.

Broad Neg and Dis were associated with lower social rapport at 24 years.

Self-rated Neg was associated with male gender and lower mental well-being at 23 years, depressive and generalised anxiety disorders at 24 years and lower social rapport at 24 years.

Associations between psychotic disorder and PRSs and other variables

The results of this secondary analysis are shown in Supplementary Table 8.

Psychotic disorder was not associated with schizophrenia PRS (odds ratio 1.10 [95% CI 0.85–1.42], P = 0.483). It was not associated with other PRSs at P < 0.001, but was associated with lower mental well-being at 23 years, depressive and generalised anxiety disorders at 24 years and lower social rapport at 24 years.

Additional secondary analysis exploring subdimensions of positive psychotic experiences and CAPE questions

Having obtained the above results, we conducted an additional secondary exploratory factor analysis of the 12 types of hallucination and delusion experience in the PLIKS interview, to identify further substructure among these experiences (see Supplementary Method and Results and Supplementary Table 9 for further details). We identified two factors: the first (labelled first-rank delusions) comprised delusions of control, and thought insertion, withdrawal and broadcast; the second (labelled paranoid) comprised auditory and visual hallucinations, delusions of being spied on and delusions of persecution.

On logistic regression analysis, the presence of first-rank delusion experiences was nominally associated with higher schizophrenia PRS (n = 2535, odds ratio 7.35 [95% CI 2.10–25.77], P = 0.002), but the presence of paranoid experiences was not (n = 2526, odds ratio 1.01 [95% CI 0.84–1.22], P = 0.929) (Supplementary Fig. 3).

We also conducted exploratory factor analysis of the ten individual CAPE questions but, because the first component dominated, we did not conduct further analysis.

Discussion

Against expectation, none of the primary psychotic experience dimensions was associated with schizophrenia PRS.

Interviewer-rated positive dimension

In contrast to the lack of association for the current interviewer-rated positive psychotic experience dimension, positive schizotypal experiences, as assessed by interview, have been associated with higher schizophrenia PRS derived from an earlier GWASReference Van Os, Van der Steen, Islam, Gülöksüz, Rutten and Simons26 (n = 523). The reasons for variation in results are not clear, but the schizotypy study had a broader age range (inclusion criteria 16–50 years, mean age 31.1 years (s.d. 10.7)) and, in addition to psychotic experiences, included, for example, magical ideation and derealisation.

In ALSPAC, there was no association between positive psychotic experiences from interviews at 12 or 18 years and an earlier schizophrenia PRS,Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13 but there was an association for self-rated positive psychotic experiences at 16 years.Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 In addition to differences in assessment method (self-rated versus interview) and time frame, there were some differences in participants between the 16- and 24-year assessments, but we did not have the 16-year PLIKS questionnaire data to investigate further. However, consistent with the current study, there was no association with schizophrenia PRS in a combined analysis of self-rated positive psychotic experiences in ALSPAC at 16 years and two adolescent twin samples.Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23 This is because participants without psychotic experiences often had a schizophrenia PRS similar to those with high psychotic experience scores.

There is an association between the presence of self-rated positive psychotic experiences and schizophrenia PRS in a larger sample of middle-/older-aged adults, but of small effect size (odds ratio 1.09 [95% CI 1.06–1.12]) and non-specific, showing similar associations with other PRSs.Reference Legge, Jones, Kendall, Pardiñas, Menzies and Bracher-Smith24

In clinical samples, most studies of probands with schizophrenia show a lack of association between the number/severity of positive symptoms and schizophrenia PRS,Reference Fanous, Zhou, Aggen, Bergen, Amdur and Duan4,Reference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6,Reference Taylor, de Vries, van Loo and Kendler16,Reference Ahangari, Bustamante, Kirkpatrick, Nguyen, Verrelli and Fanous17 but there is an association in bipolar spectrum disorders, especially for mood-incongruent psychotic symptoms.Reference Allardyce, Leonenko, Hamshere, Pardiñas, Forty and Knott19,Reference Allardyce, Cardno, Gordon-Smith, Jones, Di Florio and Walters20 This may be because of greater variation in positive symptoms and schizophrenia liability within bipolar than schizophrenia samples.Reference Owen, Legge, Rees, Walters and O’Donovan15

Some studies of broad psychosis spectrum samples also show associations between the number/severity of positive symptoms and schizophrenia PRS,Reference Quattrone, Reininghaus, Richards, Tripoli, Ferraro and Quattrone5,Reference Smigielski, Papiol, Theodoridou, Heekeren, Gerstenberg and Wotruba18 but not consistently.Reference Jonas, Lencz, Li, Malhotra, Perlman and Fochtmann21,Reference Sengupta, MacDonald, Fathalli, Yim, Lepage and Iyer22 Considerable methodological heterogeneity makes comparison of these studies difficult.

In the current study, positive psychotic experiences were associated with lower mental well-being, depressive and anxiety disorders and lower childhood IQ, consistent with other studies.Reference Siebald, Khandaker, Zammit, Lewis and Jones34,Reference Kelleher and Cannon36,Reference Cardno, Selzam, Freeman and Ronald37 Positive psychotic experiences have also been associated with other risk factors, including childhood adversity and cannabis use.Reference Kelleher and Cannon36,Reference Cardno, Selzam, Freeman and Ronald37

There were no associations of global hallucination or delusion experiences, paranoid experiences or psychotic disorder with schizophrenia PRS. First-rank delusion experiences were nominally associated, but important caveats are the very small number of participants with these experiences (n = 5 (0.2%) with PRS), a wide confidence interval and the risk of a false positive result from multiple testing in this additional secondary analysis.

The concept of first-rank symptoms was devised with a view to identifying relatively specific symptoms of schizophrenia, but these have been de-emphasised in ICD-1138 and DSM-5-TR,39 for reasons including that they are also found in other conditions such as mania. However, as noted above, there is evidence that, within bipolar spectrum disorders, mood-incongruent psychotic symptoms, which include first-rank symptoms, are associated with higher schizophrenia PRS.Reference Allardyce, Leonenko, Hamshere, Pardiñas, Forty and Knott19

In view of this, the exploratory and highly provisional association between first-rank delusions and schizophrenia PRS is interesting, but requires independent confirmation.

Interviewer-rated negative dimension

In contrast to the current findings, parent-rated negative symptoms were associated with higher scores on an earlier schizophrenia PRS in the combined analysis of ALSPAC assessments at 16 years and two adolescent twin samples.Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23

Associations have also been found between negative/disorganised schizotypal features, as assessed by interview, and schizophrenia PRS,Reference Ahangari, Bustamante, Kirkpatrick, Nguyen, Verrelli and Fanous17,Reference Van Os, Van der Steen, Islam, Gülöksüz, Rutten and Simons26 but it is unclear whether it was the negative, disorganised or both phenomena that contributed to the association.

In clinical samples of schizophrenia and other psychotic disorders, negative symptom dimensions have frequently been associated with genetic loading for schizophrenia, including PRS.Reference Taylor, de Vries, van Loo and Kendler16 Again there is a caveat that the negative dimensions may include disorganised symptoms. Some studies that attempted to disaggregate these symptoms,Reference Fanous, Zhou, Aggen, Bergen, Amdur and Duan4 or examined the independence of their associations,Reference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6 found that the association was predominantly with disorganised symptoms.

A further complication in clinical samples is that negative symptoms could be markers of primary developmental aetiological processes and/or secondary to having a psychotic disorder – for example, to the effects of positive symptoms, medication or social isolation.

In a study of adolescent twins at 16 years, i.e. prior to the main age at onset range of psychotic disorders, parent-rated negative symptoms (presumed to be predominantly primary symptoms) were associated with male gender, lower parental socioeconomic status, cumulative pre/perinatal complications, lower cognitive functioning in childhood and lower educational attainment.Reference Cardno, Selzam, Freeman and Ronald37 The association with male gender is also often found in clinical samples of psychotic disorders, along with indices of relatively severe chronic illnessReference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 and cognitive impairment.Reference de Dominguez, Viechtbauer, Simons, Van Os and Krabbendam40

In the current study there was an association with lower social rapport, which could result in social isolation, and a nominal association with lower childhood IQ; otherwise, the pattern of associations was not strikingly similar to those in adolescent population or in clinical studies. It is unclear, therefore, how much the one-off interviewer observations at 24 years are able to identify the same phenotypes as in the other studies.

Interviewer-rated disorganised dimension

Regarding the interviewer-rated disorganised dimension, there has been little comparable research in general population samples. As mentioned above, associations have been found between interview-based negative/disorganised schizotypal phenotypes and higher schizophrenia PRS,Reference Ahangari, Bustamante, Kirkpatrick, Nguyen, Verrelli and Fanous17,Reference Van Os, Van der Steen, Islam, Gülöksüz, Rutten and Simons26 but it is unclear which phenomena contributed to the association.

In clinical schizophrenia and psychosis samples, there is relatively consistent evidence that the disorganised symptom dimension has substantial heritabilityReference Rietkerk, Boks, Sommer, Liddle, Ophoff and Kahn9,Reference Rijsdijk, Gottesman and Cardno10 and is associated with higher schizophrenia PRS.Reference Fanous, Zhou, Aggen, Bergen, Amdur and Duan4,Reference Legge, Cardno, Allardyce, Dennison, Hubbard and Pardiñas6,Reference Ahangari, Bustamante, Kirkpatrick, Nguyen, Verrelli and Fanous17

In population samples there are investigations of self-rated cognitive disorganisation, which shows association with schizophrenia PRS.Reference Pain, Dudbridge, Cardno, Freeman, Lu and Lundstrom23 However, because there is little correlation between self- and observer-rated disorganised symptoms in clinical samples,Reference Cardno, el din Nasser, du Toit, Rehman, McIlrae and Variend41 the relevance of the self-rated cognitive disorganisation studies to the current interviewer-rated disorganised dimension is unclear.

In clinical samples, the disorganised symptom dimension is associated with lower cognitive functioning,Reference de Dominguez, Viechtbauer, Simons, Van Os and Krabbendam40 including lower premorbid IQ,Reference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 which is consistent with the nominal association with lower childhood IQ in the current study. In addition, the apparently odd speech and behaviour of people with disorganised symptoms is consistent with the association with lower social rapport in the current study.

Nevertheless, the lack of association with schizophrenia PRS in the current study raises the question of how similar or different are the aetiological processes underlying interviewer-observed disorganised phenomena at a single time point in the general population compared with clinically observed disorganised symptoms, which are often clearest during acute psychotic episodes.

Self-rated negative dimension

In contrast to the results for the current self-rated negative dimension based on the CAPE questionnaire at 24 years, there was an association between the self-rated negative dimension based on CAPE at 16 years in ALSPAC and an earlier schizophrenia PRS.Reference Jones, Stergiakouli, Tansey, Hubbard, Heron and Cannon13,Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 As with the positive dimension, we did not have the CAPE data at 16 years to further investigate this difference.

In other general population studies of the CAPE self-rated negative dimension, results have also been inconsistent, in that both associationReference Quattrone, Reininghaus, Richards, Tripoli, Ferraro and Quattrone5 and absence of associationReference Van Os, Van der Steen, Islam, Gülöksüz, Rutten and Simons26 with schizophrenia PRS have been found.

In contrast to the lack of association with schizophrenia PRS in the current study, there were substantive associations with depression, anxiety, neuroticism and autism PRSs, although not of sufficient effect size to be clinically actionable. Association with neuroticism PRS was also found at 16 years in ALSPAC.Reference Jones, Heron, Hammerton, Stochl, Jones and Cannon14 Self-rated negative schizotypal experiences have also been associated with depression and neuroticism PRSs in another general population sample.Reference Docherty, Shabalin, Adkins, Mann, Krueger and Bacanu25

Consistent with the PRS results, higher scores on the self-rated negative dimension were associated with the presence of depressive and generalised anxiety disorders, as well as with lower mental well-being and social rapport, at 24 years.

There was no correlation between interviewer- and self-rated negative dimensions in the current study, which suggests that they may be assessing phenotypes with notably different aetiologies. Low correlations between self- and observer-rated negative symptoms have also been found in some clinical samples.Reference Cardno, el din Nasser, du Toit, Rehman, McIlrae and Variend41

In summary, self-rated negative symptoms were not associated with schizophrenia PRS in the current study, and show inconsistent associations in other studies. They may be influenced by genetic risk variants for other disorders, but confirmation in further independent samples would be valuable.

Strengths and limitations

To our knowledge, this is the first birth cohort study to assess distinct positive, negative and disorganised psychotic experience dimensions, including the use of interviewer observations for negative and disorganised symptoms, and additionally using self-rated negative symptoms, in large sample sizes of 2500+ at 24 years.

Despite assessment around the peak age at onset of schizophrenia,Reference Tandon, Nasrallah, Akbarian, Carpenter, DeLisi and Gaebel7 clearly present interview-based psychotic experiences remained infrequent. This limited statistical power and exploration of the dimension construct, especially regarding the gradient of scores including co-occurring experiences.

Results could have differed if we had used other definitions of psychotic experience dimensions. We explored the use of factor scores, but were concerned about the stability of factors given the low frequency of some experiences, which also precluded splitting the sample for exploratory and confirmatory factor analysis. Furthermore, the use of simple phenotypes based on whether or not experiences were clearly present simplified interpretation and comparison with similar definitions in clinical samples.Reference Cardno, Allardyce, Bakker, Toulopoulou, Kravariti and Picchioni8 These simple phenotypes also show similar levels of familial aggregation to phenotypes based on factor scores in clinical samples.Reference Cardno, Jones, Murphy, Sanders, Asherson and Owen2,Reference Cardno, Sham, Murray and McGuffin3

The results could also have differed if we had used other approaches to generating PRSs. However, lack of association of positive psychotic experiences and negative symptoms with schizophrenia PRS was also found in a larger sample of adolescent twins using other PRS approaches.Reference Cardno, Selzam, Freeman and Ronald37,Reference Maxwell, Ronald, Cardno, Breen, Rimfeld and Vassos42 Additionally, the approach in the current study facilitated comparison with other studies, most of which also used the GWAS discovery sample P-value threshold approach.

The sample size was substantial, but combination with other samples in meta-analyses may be required to detect associations of small effect.

There were considerable missing data, due to participant attrition between inception and 24 years. Individuals were more likely to have missing data at 24 years if they were male, had greater socioeconomic disadvantage or had had more severe psychotic experiences at 18 years.Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12 Observed and imputed estimates are very similar for the frequency of any definite positive psychotic experience and psychotic disorder at 12–24 years,Reference Sullivan, Kounali, Cannon, David, Fletcher and Holmans12 but biased estimates are still possible, including because of data not missing at random.

There is also an association between non-participation and higher schizophrenia PRS in ALSPAC, leading to reduced power for analyses of schizophrenia and genetically related psychiatric phenotypes, and potentially biased estimates, even with imputation due to data not missing at random.Reference Martin, Tilling, Hubbard, Stergiakouli, Thapar and Davey Smith43

Inverse probability weighting may also be used to adjust for missing data, but issues include the assumption that, for example (if being male is a predictor of missing data), male non-participants would have similar associations to male participants.Reference Seaman and White44

The genetic analysis was confined to associations with PRS and did not include rarer schizophrenia risk variants.Reference Owen, Legge, Rees, Walters and O’Donovan15

The sample was predominantly of White European ancestry, and exclusively so for the PRS analyses, which minimised the risk of confounding by population stratification. However, further studies in more ethnically diverse samples would be valuable, which is a major focus of the Psychiatric Genomics Consortium (https://pgc.unc.edu).

The results of this study suggest that positive, negative and disorganised experience/symptom dimensions, as defined here and assessed in this general population cohort of young adults, are not strongly associated with polygenic liability to schizophrenia, although true associations hidden by methodological constraints are not excluded, e.g. due to small effect sizes, missing data, low phenotype base rates or misclassification, or PRS limitations.

Positive psychotic experiences may be (modestly and non-specifically) influenced by commonly occurring risk alleles for schizophrenia, with PRS associations seen more from middle age onwards, as people with high schizophrenia liability but no lifetime psychotic experiences become fewer over time. Future research in ALSPAC and other samples as participants age may clarify whether this is the case.

In clinical samples, schizophrenia PRS is most consistently associated with disorganised and/or negative symptoms. The interviewer-rated negative and disorganised symptoms in the current study probably have notably different aetiologies. Also, the self-rated negative symptoms may be better indicators of social withdrawal/low motivation due to polygenic liability to depression, anxiety, neuroticism or autism than schizophrenia.

The highly provisional secondary finding, that first-rank delusions might be indicators of higher polygenic liability to schizophrenia, is of interest, but needs confirmation in other samples where information on first-rank symptoms is available before substantive conclusions can be drawn.

Supplementary material

The supplementary material is available online at https://doi.org/10.1192/bjo.2025.10825

Data availability

The Avon Longitudinal Study of Parents and Children (ALSPAC) study website contains details of all the data that are available, through a fully searchable data dictionary and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). Access to ALSPAC data is through a system of managed open access.

Acknowledgements

We thank all the families who took part in this study, the midwives for their help in recruiting them and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses.

Author contributions

Conception and design of the study: A.G.C., H.H., S.E.L., J.T.R.W., S.Z., H.J.J. Data acquisition: H.J.J., S.Z. Analysis: A.G.C., H.J.J., H.H. Interpretation of findings: led by A.G.C. Drafting of manuscript: led by A.G.C. Review of drafts and final approval: all authors. All authors agree to be accountable for all aspects of the work. A.G.C. is the guarantor of all analyses.

Funding

The UK Medical Research Council and Wellcome (grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and A.G.C. will serve as guarantor for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). This research was specifically funded by the UK Medical Research Council (S.Z., grant no. MR/M006727/1). Genome-wide genotyping data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America), using support from 23 and Me.

Declaration of interest

J.T.R.W. reports grants from Akrivia Health and Takeda Pharmaceutical Company Ltd, outside the scope of the submitted work. All other authors declare no competing interests.

References

Dazzi, F, Shafer, A. Meta-analysis of the factor structure of the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS). Schizophr Res 2024; 274: 464–72.10.1016/j.schres.2024.10.027CrossRefGoogle ScholarPubMed
Cardno, AG, Jones, LA, Murphy, KC, Sanders, RD, Asherson, P, Owen, MJ, et al. Dimensions of psychosis in affected sibling pairs. Schizophr Bull 1999; 25: 841–50.10.1093/oxfordjournals.schbul.a033423CrossRefGoogle ScholarPubMed
Cardno, AG, Sham, PC, Murray, RM, McGuffin, P. Twin study of symptom dimensions in psychoses. Br J Psychiatry 2001; 179: 3945.10.1192/bjp.179.1.39CrossRefGoogle ScholarPubMed
Fanous, AH, Zhou, B, Aggen, SH, Bergen, SE, Amdur, RL, Duan, J, et al. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry 2012; 169: 1309–17.10.1176/appi.ajp.2012.12020218CrossRefGoogle ScholarPubMed
Quattrone, D, Reininghaus, U, Richards, AL, Tripoli, G, Ferraro, L, Quattrone, A, et al. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Transl Psychiatry 2021; 11: 423.10.1038/s41398-021-01526-0CrossRefGoogle ScholarPubMed
Legge, SE, Cardno, AG, Allardyce, J, Dennison, C, Hubbard, L, Pardiñas, AF, et al. Associations between schizophrenia polygenic liability, symptom dimensions, and cognitive ability in schizophrenia. JAMA Psychiatry 2021; 78: 1143–51.10.1001/jamapsychiatry.2021.1961CrossRefGoogle ScholarPubMed
Tandon, R, Nasrallah, H, Akbarian, S, Carpenter, WT Jr, DeLisi, LE, Gaebel, W, et al. The schizophrenia syndrome, circa 2024: what we know and how that informs its nature. Schizophr Res 2024; 264: 128.10.1016/j.schres.2023.11.015CrossRefGoogle ScholarPubMed
Cardno, AG, Allardyce, J, Bakker, SC, Toulopoulou, T, Kravariti, E, Picchioni, MM, et al. Associations of psychotic symptom dimensions with clinical and developmental variables in twin and general clinical samples. Br J Psychiatry 2025; 226: 1623.10.1192/bjp.2024.129CrossRefGoogle ScholarPubMed
Rietkerk, T, Boks, MPM, Sommer, IE, Liddle, PF, Ophoff, RA, Kahn, RS. The genetics of symptom dimensions of schizophrenia: review and meta-analysis. Schizophr Res 2008; 102: 197205.10.1016/j.schres.2008.01.023CrossRefGoogle ScholarPubMed
Rijsdijk, FV, Gottesman, MG, Cardno, AG. Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 8998.10.1002/ajmg.b.31145CrossRefGoogle ScholarPubMed
Ronald, A, Sieradzka, D, Cardno, AG, Haworth, CM, McGuire, P, Freeman, D. Characterization of psychotic experiences in adolescence using the specific psychotic experiences questionnaire: findings from a study of 5000 16-year-old twins. Schizophr Bull 2014; 40: 868–77.10.1093/schbul/sbt106CrossRefGoogle ScholarPubMed
Sullivan, SA, Kounali, D, Cannon, M, David, AS, Fletcher, PC, Holmans, P, et al. A population-based cohort study examining the incidence and impact of psychotic experiences from childhood to adulthood, and prediction of psychotic disorder. Am J Psychiatry 2020; 177: 308–17.10.1176/appi.ajp.2019.19060654CrossRefGoogle ScholarPubMed
Jones, HJ, Stergiakouli, E, Tansey, KE, Hubbard, L, Heron, J, Cannon, M, et al. Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiatry 2016; 73: 221–8 10.1001/jamapsychiatry.2015.3058CrossRefGoogle ScholarPubMed
Jones, HJ, Heron, J, Hammerton, G, Stochl, J, Jones, PB, Cannon, M, et al. Investigating the genetic architecture of general and specific psychopathology in adolescence. Transl Psychiatry 2018; 8: 145.10.1038/s41398-018-0204-9CrossRefGoogle ScholarPubMed
Owen, MJ, Legge, SE, Rees, E, Walters, JTR, O’Donovan, MC. Genomic findings in schizophrenia and their implications. Mol Psychiatry 2023; 28: 3638–47.10.1038/s41380-023-02293-8CrossRefGoogle ScholarPubMed
Taylor, J, de Vries, YA, van Loo, HM, Kendler, KS. Clinical characteristics indexing genetic differences in schizophrenia: a systematic review. Mol Psychiatry 2023; 28: 883–90.10.1038/s41380-022-01850-xCrossRefGoogle ScholarPubMed
Ahangari, M, Bustamante, D, Kirkpatrick, R, Nguyen, TH, Verrelli, BC, Fanous, A, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. Br J Psychiatry 2023; 223: 301–8.10.1192/bjp.2022.179CrossRefGoogle ScholarPubMed
Smigielski, L, Papiol, S, Theodoridou, A, Heekeren, K, Gerstenberg, M, Wotruba, D, et al. Polygenic risk scores across the extended psychosis spectrum. Transl Psychiatry 2021; 11: 600.10.1038/s41398-021-01720-0CrossRefGoogle ScholarPubMed
Allardyce, J, Leonenko, G, Hamshere, M, Pardiñas, AF, Forty, L, Knott, S, et al. Association between schizophrenia-related polygenic liability and the occurrence and level of mood-incongruent psychotic symptoms in bipolar disorder. JAMA Psychiatry 2018; 75: 2835.10.1001/jamapsychiatry.2017.3485CrossRefGoogle ScholarPubMed
Allardyce, J, Cardno, AG, Gordon-Smith, K, Jones, L, Di Florio, A, Walters, JTR, et al. Specificity of polygenic signatures across symptom dimensions in bipolar disorder: an analysis of UK Bipolar Disorder Research Network data. Lancet Psychiatry 2023; 10: 623–31.10.1016/S2215-0366(23)00186-4CrossRefGoogle ScholarPubMed
Jonas, KG, Lencz, T, Li, K, Malhotra, AK, Perlman, G, Fochtmann, LJ, et al. Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders. Transl Psychiatry 2019; 9: 300.10.1038/s41398-019-0612-5CrossRefGoogle ScholarPubMed
Sengupta, SM, MacDonald, K, Fathalli, F, Yim, A, Lepage, M, Iyer, S, et al. Polygenic risk score associated with specific symptom dimensions in first-episode psychosis. Schizophr Res 2017; 184: 116–21.10.1016/j.schres.2016.11.039CrossRefGoogle ScholarPubMed
Pain, O, Dudbridge, F, Cardno, AG, Freeman, D, Lu, Y, Lundstrom, S, et al. Genome-wide analysis of adolescent psychotic-like experiences shows genetic overlap with psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 2018; 177: 416–25.10.1002/ajmg.b.32630CrossRefGoogle ScholarPubMed
Legge, SE, Jones, HJ, Kendall, KM, Pardiñas, AF, Menzies, G, Bracher-Smith, M, et al. Association of genetic liability to psychotic experiences with neuropsychotic disorders and traits. JAMA Psychiatry 2019; 76: 1256–65.10.1001/jamapsychiatry.2019.2508CrossRefGoogle ScholarPubMed
Docherty, AR, Shabalin, AA, Adkins, DE, Mann, F, Krueger, RF, Bacanu, SA, et al. Molecular genetic risk for psychosis is associated with psychosis risk symptoms in a population-based UK cohort: findings from Generation Scotland. Schizophr Bull 2020; 46: 1045–52.10.1093/schbul/sbaa042CrossRefGoogle Scholar
Van Os, J, Van der Steen, Y, Islam, MA, Gülöksüz, S, Rutten, BP, Simons, CJ. Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience. Psycholl Med 2017; 47: 2421–37.10.1017/S0033291717000915CrossRefGoogle ScholarPubMed
Derks, EM, Vorstman, JAS, Ripke, S, Kahn, RS. The Schizophrenia Psychiatric Genomic Consortium, Ophoff RA. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. PLoS One 2012; 7: e37852.10.1371/journal.pone.0037852CrossRefGoogle ScholarPubMed
Konings, M, Bak, M, Hanssen, M, van Os, J, Krabbendam, L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 2006; 114: 5561.10.1111/j.1600-0447.2005.00741.xCrossRefGoogle Scholar
Trubetskoy, V, Pardiñas, AF, Qi, T, Panagiotaropoulou, G, Awasthi, S, Bigdeli, TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 2022; 604: 502–8.10.1038/s41586-022-04434-5CrossRefGoogle ScholarPubMed
Boyd, A, Golding, J, Macleod, J, Lawlor, DA, Fraser, A, Henderson, J, et al. Cohort profile: the children of the 90s’--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 2013; 42: 111–27.10.1093/ije/dys064CrossRefGoogle Scholar
Fraser, A, Macdonald-Wallis, C, Tilling, K, Boyd, A, Golding, J, Davey Smith, G, et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 2013; 42: 97110.10.1093/ije/dys066CrossRefGoogle ScholarPubMed
Northstone, K, Lewcock, M, Groom, A, Boyd, A, Macleod, J, Timpson, N, et al. The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019. Wellcome Open Res 2019; 4: 51.10.12688/wellcomeopenres.15132.1CrossRefGoogle ScholarPubMed
Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap) -- a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–81.10.1016/j.jbi.2008.08.010CrossRefGoogle ScholarPubMed
Siebald, C, Khandaker, GM, Zammit, S, Lewis, G, Jones, PB. Association between childhood psychiatric disorders and psychotic experiences in adolescence: a population-based longitudinal study. Compr Psychiatry 2016; 69: 4552.10.1016/j.comppsych.2016.05.004CrossRefGoogle ScholarPubMed
Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MAR, Bender, D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–75.10.1086/519795CrossRefGoogle Scholar
Kelleher, I, Cannon, M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med 2011; 41: 1–6.10.1017/S0033291710001005CrossRefGoogle Scholar
Cardno, AG, Selzam, S, Freeman, D, Ronald, A. Psychotic-like experiences in adolescence occurring in combination or isolation: associations with schizophrenia risk factors. Psychiatr Res Clin Pract 2021; 3: 6775.10.1176/appi.prcp.20200010CrossRefGoogle ScholarPubMed
World Health Organization (WHO). International Classification of Diseases, Eleventh Revision (ICD-11). WHO, 2019 (https://icd.who.int/browse11).Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) (5th ed.; Text Revision). American Psychiatric Publishing, 2022.Google Scholar
de Dominguez, MG, Viechtbauer, W, Simons, CJ, Van Os, J, Krabbendam, L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull 2009; 135: 157–71.10.1037/a0014415CrossRefGoogle Scholar
Cardno, AG, el din Nasser, S, du Toit, D, Rehman, F, McIlrae, S, Variend, H, et al. Relationships between psychotic and affective symptoms, schizotypal and dissociative phenomena, and adverse life events among individuals with psychotic disorders. J Psychiatr Intensive Care 2024; 20: 917.10.20299/jpi.2023.010CrossRefGoogle Scholar
Maxwell, J, Ronald, A, Cardno, AG, Breen, G, Rimfeld, K, Vassos, E. Genetic and geographical associations with six dimensions of psychotic experiences in adolesence. Schizophr Bull 2023; 49: 319–28.10.1093/schbul/sbac149CrossRefGoogle ScholarPubMed
Martin, J, Tilling, K, Hubbard, L, Stergiakouli, E, Thapar, A, Davey Smith, G, et al. Association of genetic risk for schizophrenia with nonparticipation over time in a population-based cohort study. Am J Epidemiol 2016; 183: 1149–58.10.1093/aje/kww009CrossRefGoogle Scholar
Seaman, SR, White, IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 2013; 22: 278–95.10.1177/0962280210395740CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Distribution of psychotic experience dimension scores from interview assessments

Figure 1

Table 2 Regression analysis of psychotic experience dimensions on polygenic risk scoresa

Supplementary material: File

Cardno et al. supplementary material 1

Cardno et al. supplementary material
Download Cardno et al. supplementary material 1(File)
File 42.1 KB
Supplementary material: File

Cardno et al. supplementary material 2

Cardno et al. supplementary material
Download Cardno et al. supplementary material 2(File)
File 42.1 KB
Supplementary material: File

Cardno et al. supplementary material 3

Cardno et al. supplementary material
Download Cardno et al. supplementary material 3(File)
File 87.3 KB
Supplementary material: File

Cardno et al. supplementary material 4

Cardno et al. supplementary material
Download Cardno et al. supplementary material 4(File)
File 16.8 KB
Supplementary material: File

Cardno et al. supplementary material 5

Cardno et al. supplementary material
Download Cardno et al. supplementary material 5(File)
File 57.5 KB
Submit a response

eLetters

No eLetters have been published for this article.